Arase Y - Search Results

1

Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib.

Kasuya K, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Eguchi Y, Hashimoto M, Kumada H. Kasuya K, et al. Among authors: arase y. Intern Med. 2021 Feb 1;60(3):345-351. doi: 10.2169/internalmedicine.5185-20. Epub 2020 Sep 19. Intern Med. 2021. PMID: 32963154 Free PMC article.

2

[A case of intrahepatic cholangiocarcinoma with liver cirrhosis presenting atypical images].

Tubota A, Ikeda K, Saitoh S, Arase Y, Chayama K, Kumada H. Tubota A, et al. Among authors: arase y. Nihon Shokakibyo Gakkai Zasshi. 1992 Aug;89(8):1532-7. Nihon Shokakibyo Gakkai Zasshi. 1992. PMID: 1328729 Japanese. No abstract available.

3

Alanine aminotransferase and HCV-RNA responses following interferon therapy of HCV-RNA positive chronic hepatitis.

Arase Y, Kumada H, Chayama K, Tsubota A, Ikeda K, Saitoh S, Sakai Y, Matsumoto T, Kobayashi M. Arase Y, et al. Gastroenterol Jpn. 1992 Oct;27(5):646-51. doi: 10.1007/BF02774980. Gastroenterol Jpn. 1992. PMID: 1330798

4

Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. An analysis by the Cox proportional hazard model.

Ikeda K, Kumada H, Saitoh S, Arase Y, Chayama K. Ikeda K, et al. Among authors: arase y. Cancer. 1991 Nov 15;68(10):2150-4. doi: 10.1002/1097-0142(19911115)68:10<2150::aid-cncr2820681011>3.0.co;2-f. Cancer. 1991. PMID: 1655202

5

Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C.

Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H. Chayama K, et al. Among authors: arase y. Hepatology. 1991 Jun;13(6):1040-3. Hepatology. 1991. PMID: 1711001 Clinical Trial.

6

[Clinical features and viral markers in patients with chronic hepatitis positive for both HBs antigen and anti-C-100 antibody].

Chayama K, Arase Y, Saito S, Ikeda K, Kumada H, Matsumoto T, Kobayashi M, Sakai Y, Morinaga T. Chayama K, et al. Among authors: arase y. Nihon Shokakibyo Gakkai Zasshi. 1991 Sep;88(9):2113-8. Nihon Shokakibyo Gakkai Zasshi. 1991. PMID: 1795421 Japanese.

7

Hepatoblastoma in an 82-year-old man. An autopsy case report.

Oda H, Honda K, Hara M, Arase Y, Ikeda K, Kumada H. Oda H, et al. Among authors: arase y. Acta Pathol Jpn. 1990 Mar;40(3):212-8. doi: 10.1111/j.1440-1827.1990.tb03325.x. Acta Pathol Jpn. 1990. PMID: 2163188 Review.

8

Hepatic squamous cell carcinoma with hypercalcemia in liver cirrhosis.

Arase Y, Endo Y, Hara M, Kumada H, Ikeda K, Yoshiba A. Arase Y, et al. Acta Pathol Jpn. 1988 May;38(5):643-50. doi: 10.1111/j.1440-1827.1988.tb02336.x. Acta Pathol Jpn. 1988. PMID: 2463731

9

[Remission state and five-year survival after transcatheter arterial embolization therapy in patients with hepatocellular carcinoma].

Ikeda K, Kumada H, Arase Y, Chayama K, Saitoh S, Komeichi H, Yoshiba A, Irimoto M. Ikeda K, et al. Among authors: arase y. Nihon Shokakibyo Gakkai Zasshi. 1989 Sep;86(9):2215-22. Nihon Shokakibyo Gakkai Zasshi. 1989. PMID: 2555608 Japanese.

10

[Effects and side effects of long-term administration of oral antitumor agents in patients with hepatocellular carcinoma--especially, relation to aggravation of liver function].

Ikeda K, Kumada H, Arase Y, Nakamura I, Chayama K, Murashima N, Takeuchi K, Nakajima M, Yoshiba A, Irimoto M. Ikeda K, et al. Among authors: arase y. Nihon Shokakibyo Gakkai Zasshi. 1987 Oct;84(10):2377-85. Nihon Shokakibyo Gakkai Zasshi. 1987. PMID: 2830421 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

521 results

Search Page